Long-Acting Octreotide for the Treatment of Congenital Hyperinsulinism
Dr. Khalid Hussain, a leading pediatric endocrinologist specializing in congenital hyperinsulinism (HI) presented information on the use of long-acting octreotide as a medical therapy for patients with HI at the Congenital Hyperinsulinism International Endocrine Society Meeting in Berkeley, California on June 15, 2013. Dr. Hussain presented information on published studies and on an ongoing study … Read more